Delivery Order 36C26226D0036-36C26226N0235
- Not listed
- RLS (USA) Inc., a foreign-owned radiopharmacy company, has been awarded a delivery order valued at $91,658.40 by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) for the supply of NETSPOT GA-68 (Gallium-68 Dotatate), a radiopharmaceutical used in nuclear medicine diagnostic imaging. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 31, 2026, and will be performed at the contractor's facility in...
- RLS (USA) Inc., a radiopharmacy company specializing in nuclear medicine products, received a delivery order award from the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) on January 1, 2026, for the supply of NETSPOT GA-68 (Gallium-68 Dotatate), a radiopharmaceutical used in diagnostic imaging. This firm fixed-price delivery order carries a ceiling value of $91,658.40 and is scheduled for completion by December 31, 2026. The contract will be performed in...
- This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 21 to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract, valued at $378,281.55, is for the delivery of radiopharmaceuticals to support nuclear medicine diagnostic services at VA medical centers. RLS (USA) Inc. is an established federal contractor, holding multiple Indefinite Delivery Vehicles (IDVs) with the VA and the Defense Health Agency...
- This is a definitive contract awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, for the supply of radiopharmaceuticals and related services. The $878,999.37 firm-fixed price contract is not set aside and has an ultimate completion date of September 17, 2024. RLS (USA) Inc. specializes in providing a wide range of molecular imaging products, including medical isotopes and radiopharmaceuticals, to support nuclear medicine...
- The U.S. Department of Veterans Affairs (VA) has awarded a firm-fixed price delivery order contract to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, for the supply of non-pet radiopharmaceuticals. The contract, valued at $232,388.97, has an ultimate completion date of March 31, 2025. RLS (USA) Inc. is a small business that specializes in providing a range of medical isotopes and radiopharmaceutical products to support nuclear medicine diagnostic services at VA medical centers...
- This federal contract award to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, is a delivery order with a firm fixed price of $22,914.60 and a period of performance ending on December 31, 2024. The contract is for the delivery of the radiopharmaceutical product NETSPOT GA-68 to the Department of Veterans Affairs (VA), specifically the VA Integrated Service Network 2 (VISN 2). RLS (USA) Inc. is an experienced federal contractor, holding several Indefinite Delivery Vehicles...
- This federal contract award is for the delivery of radiopharmaceuticals to the Defense Health Agency (DHA) and the Department of Veterans Affairs (VA). The prime contractor is RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company that specializes in providing radiopharmaceuticals and related services to the U.S. federal government. The contract has a ceiling value of $299,975.67 and a completion date of September 30, 2023. It is a delivery order contract with a firm-fixed price...
- This is a delivery order contract awarded to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, by the Veterans Integrated Service Network 2 (VISN 2), a division of the U.S. Department of Veterans Affairs (VA). The contract is for the supply of NETSPOT GA-68, a radiopharmaceutical product used in nuclear medicine imaging procedures. The delivery order has a firm fixed price ceiling value of $43,537.74 and a performance period that runs through August 31, 2025. RLS (USA) Inc. is...
- This contract award to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, is for the delivery of NETSPOT GA-68 radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA). The $2,291.46 firm-fixed price contract has an ultimate completion date of August 21, 2024. RLS (USA) Inc. holds several federal contract Indefinite Delivery Vehicles (IDVs) with the VA and Defense Health Agency to facilitate the efficient procurement of its radiopharmaceutical products, including...
- This is a federal contract award to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, by the Department of Veterans Affairs (VA). The contract is for the supply of critical radiopharmaceuticals used in nuclear medicine diagnostic services at VA medical centers and military treatment facilities. The contract has a ceiling value of $315,075.54 and is a firm fixed-price purchase order with a performance period ending on February 28, 2026. RLS (USA) Inc. is a small business that...
The Department of Veterans Affairs Veterans Integrated Service Network 22 awarded a delivery order valued at $320,306.45 to RLS (USA) Inc. for the supply of radiopharmaceuticals. The contract, which was awarded on December 12, 2025, with an ultimate completion date of December 11, 2026, utilizes firm fixed price pricing and carries no set-aside designation. Performance will be conducted at RLS (USA) Inc.'s facility in Lake Mary, Florida. This delivery order falls under a larger indefinite delivery vehicle structure, enabling the VA to procure radiopharmaceuticals on an as-needed basis to support nuclear medicine diagnostic imaging services across its healthcare network. RLS (USA) Inc. is a foreign-owned radiopharmacy company operating 31 facilities across 18 states and specializing in supplying time-sensitive radiopharmaceutical products to federal healthcare agencies. The company's portfolio includes critical medical isotopes such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate (NETSPOT), which are essential for diagnostic nuclear medicine procedures serving veterans and military personnel at VA medical centers and defense health facilities nationwide. This delivery order represents one of numerous procurement actions through which RLS (USA) Inc. supports the VA's nuclear medicine diagnostic capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $320.3k | 12/10/25 |